Back to Stakeholders

Specialized Academic Departments and Institutes Independent Academic Research Groups

New York State Psychiatric Institute

United States

7 Trials

State-funded psychiatric research institute affiliated with Columbia University, located in New York City. A key site for psilocybin clinical trials including the landmark COMP360 study for treatment-resistant depression, and conducts broader research on LSD, DMT, ayahuasca, and ketamine through Columbia's Depression Evaluation Service.

Quick Facts

Type: Other
HQ: United States
Website: Visit

Sponsored Trials

7

Ketamine in the Treatment of Suicidal Depression

Start Date: June 1, 2021
Compounds: Ketamine, Placebo

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

Start Date: February 26, 2021
Compounds: Psilocybin

Temporarily not availableIV

IM Ketamine vs Midazolam for Suicidal ER Patients

Start Date: January 2, 2021
Compounds: Ketamine, Placebo

Temporarily not availableI, II

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

Start Date: January 1, 2021
Compounds: Ketamine

Ketamine Treatment Effects on Synaptic Plasticity in Depression

Start Date: October 9, 2020
Compounds: Ketamine

Ketamine for Suicidality in Bipolar Depression

Start Date: January 9, 2013
Compounds: Ketamine, Placebo

NMDA Antagonists in Bipolar Depression

Start Date: January 3, 2013
Compounds: Ketamine